BioHarvest Sciences to Present at 2026 BIO International Convention

BioHarvest Sciences Inc. announced its participation in the 2026 BIO International Convention held in San Diego, California, from June 22-25. The company will present its proprietary Botanical Synthesis™ platform, which allows for the precise, consistent, and scalable production of plant-derived compounds. This technology has implications for drug discovery, active pharmaceutical ingredients, and next-generation therapeutics. BioHarvest is seeking collaborations with pharmaceutical and life science organizations. The presentation aims to showcase the platform's potential and advance discussions for strategic partnerships, potentially creating long-term shareholder value. The company also highlighted its expanded capabilities and accelerated partner engagement efforts. Interested parties can request meetings through the BIO 1x1 Meeting platform or contact BioHarvest directly. The filing also provides background information on BIO, the BIO International Convention, and BioHarvest's business, including its Botanical Synthesis technology and its two business verticals: CDMO services and nutraceutical product development. Forward-looking statements regarding future contracts, commercialization, and market acceptance are included.